Machine learning based personalized drug response prediction for lung cancer patients

Lung cancers with a mutated epidermal growth factor receptor (EGFR) are a major contributor to cancer fatalities globally. Targeted tyrosine kinase inhibitors (TKIs) have been developed against EGFR and show encouraging results for survival rate and quality of life. However, drug resistance may affe...

Descripción completa

Detalles Bibliográficos
Autores principales: Qureshi, Rizwan, Basit, Syed Abdullah, Shamsi, Jawwad A., Fan, Xinqi, Nawaz, Mehmood, Yan, Hong, Alam, Tanvir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640729/
https://www.ncbi.nlm.nih.gov/pubmed/36344580
http://dx.doi.org/10.1038/s41598-022-23649-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640729/
https://www.ncbi.nlm.nih.gov/pubmed/36344580
http://dx.doi.org/10.1038/s41598-022-23649-0

Ejemplares similares